Larvol Delta - Clinically-Meaningful-Influenza-and-SARSCoV2-Vaccine-Responses-Following-TreatmentFree-Window-of-Obexelimab-in-patients-with-IgG4RD

obexelimab (ZB012) - Zenas BioPharma

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1898790&mode=presInfo

Guy Katz, MD,MS

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next